Isotretinoin and Long-term Antibiotic Use and Multiple Sclerosis

    Basic Details
    Date Posted
    Thursday, June 30, 2016
    Medical Product
    long-term antibiotic
    Health Outcome(s)
    multiple sclerosis

    Report 1 is a modular program-based one-time assessment of isotretinoin and long-term antibiotics, including doxycycline, minocycline, and erythromycin, and subsequent multiple sclerosis (MS) diagnoses. Report 2 is a modular program-based one-time assessment of multiple sclerosis diagnoses as defined in three different ways. The queries were run against the Mini-Sentinel Distributed Database (MSDD) for the time period of January 1, 2000 to May 31, 2013.  Modular programs are adaptable standardized programs. Results were generated using Modular Program 3; click here for more information.  Queries were distributed in July 2014. This report includes data from 17 Data Partners.
    If you are using a web page screen reader and are unable to access this document, please contact the Mini-Sentinel Operations Center for assistance by clicking on the Submit Comments link above or sending an email requesting assistance to
    The information contained on this website is provided as part of FDA's commitment to place knowledge acquired from the Mini-Sentinel pilot in the public domain as soon as possible. Please read the disclaimer.

    Additional Details
    FDA Center
    Time Period
    January 1, 2000 - May 31, 2013
    Study Type
    Modular Program
    Assessment Type
    Exploratory Analyses
    Data Sources
    Mini-Sentinel Distributed Database (MSDD)